PensionDanmark Pensionsforsikringsaktieselskab raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 44.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,160 shares of the biotechnology company’s stock after acquiring an additional 3,420 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Axon Enterprise were worth $6,256,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. raised its position in Axon Enterprise by 53.2% during the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after buying an additional 4,002 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of Axon Enterprise by 1.3% in the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after acquiring an additional 5,419 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $13,116,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Axon Enterprise during the first quarter worth about $15,067,000. Finally, Harel Insurance Investments & Financial Services Ltd. raised its holdings in Axon Enterprise by 40.7% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after purchasing an additional 4,360 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Axon Enterprise Stock Performance
AXON opened at $571.01 on Friday. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $878.62. The stock has a market cap of $46.02 billion, a P/E ratio of 236.93, a P/E/G ratio of 11.65 and a beta of 1.39. The stock’s 50 day simple moving average is $513.80 and its 200 day simple moving average is $474.59. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.93.
More Axon Enterprise News
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Strong Q2 growth and higher outlook: Axon reported second-quarter revenue of approximately $904 million, up 35% year over year and above analyst expectations. The company raised its 2026 revenue-growth forecast to 32%–34%, citing record bookings, international expansion and demand for its connected devices and software. Axon Beat Estimates and Raised Guidance, Shares Dropped
- Positive Sentiment: AI and Dedrone momentum: AI Era revenue, including Draft One automated police-report software, grew nearly 700% from a year earlier. Dedrone counter-drone revenue exceeded $100 million, supported by deployments at all 11 World Cup sites, strengthening Axon’s long-term growth narrative. Axon Stock Falls After AI, Drone Wins Fuel Q2 Earnings Beat
- Positive Sentiment: Analyst and retail support: UBS raised its price target to $600 while maintaining a Neutral rating, and retail traders showed interest in buying the post-earnings pullback. William Blair also reiterated a Buy rating, highlighting recurring-revenue growth, counter-drone demand and Axon’s expanding AI platform. UBS Raises Axon Price Target
- Neutral Sentiment: Valuation remains elevated: Axon’s rapid share-price recovery has increased scrutiny of its valuation. Some analysis considers the stock expensive on discounted cash flow and only fairly valued on sales multiples, potentially limiting further gains unless growth remains strong. Axon Stock Could Be Overvalued
- Negative Sentiment: Margins and cash flow pressured the initial reaction: Software gross margin declined to 71.3% from 75.6%, while a greater mix of professional services, memory costs and investments in new products reduced profitability. Free cash flow also turned negative, and quarterly EPS was reported as slightly below some consensus estimates, prompting an initial post-earnings selloff. Axon Posts Lower Quarterly Gross Margin
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the transaction, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the transaction, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This trade represents a 2.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 58,989 shares of company stock worth $30,527,983. Insiders own 4.20% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on AXON. Citizens Jmp restated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research report on Thursday, June 25th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. UBS Group increased their price objective on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday. Barclays boosted their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Thursday. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $730.92.
View Our Latest Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
- Five stocks we like better than Axon Enterprise
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
